NAB-PACLITAXEL
Clinical trials for NAB-PACLITAXEL explained in plain language.
Never miss a new study
Get alerted when new NAB-PACLITAXEL trials appear
Sign up with your email to follow new studies for NAB-PACLITAXEL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Race to find better Pre-Surgery treatment for aggressive breast cancer
Disease control Recruiting nowThis study is testing which of two chemotherapy drug combinations works better to shrink tumors before surgery for triple-negative breast cancer, a more aggressive type. About 520 women will receive either nab-paclitaxel with carboplatin or nab-paclitaxel with epirubicin. The mai…
Matched conditions: NAB-PACLITAXEL
Phase: PHASE2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New trial tests drug combos for aggressive breast cancer
Disease control Recruiting nowThis study is comparing two different chemotherapy combinations for women with advanced triple-negative breast cancer, a particularly aggressive form of the disease. Researchers want to see which combination works better at controlling cancer growth and has fewer side effects. Th…
Matched conditions: NAB-PACLITAXEL
Phase: PHASE2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New combo aims to zap tumors, save kidneys
Disease control Recruiting nowThis study is testing whether a combination of two drugs, tislelizumab and nab-paclitaxel, can effectively treat a type of kidney cancer located in the renal pelvis. The main goal is to control the cancer for at least one year while avoiding the need to surgically remove the enti…
Matched conditions: NAB-PACLITAXEL
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC